Esomeprazole: Clinical Trials

152 trials of Esomeprazole, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

95 completed, 33 unknown, 9 withdrawn, 7 recruiting. 152 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 4152Completed 95, Unknown 33, Withdrawn 9, Recruiting 7, Not yet recruiting 4, Enrolling by invitation 2, Active not recruiting 1, Terminated 1

Follow Esomeprazole: new trials by email Literature Review of Esomeprazole trials Research Report on Esomeprazole

Trials (filtered) newest first · largest first

All 152 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Esomeprazole Plus Sucralfate for Post-ESD Ulcer Healing
Esomeprazole (Intravenous), Esomeprazole (Oral), Sucralfate Suspension - Early Gastric Cancer, Gastric Dysplasia
Phase 4Not yet recruitingLanZhou University1202026-04-202026-03-23
Effects of Adjunctive N-Acetylcysteine and Curcumin on Helicobacter Pylori Eradication and Dyspeptic Symptoms: A Randomized Controlled Trial
Esomeprazole + Amoxicillin + Levofloxacin + Bismuth, N-acetylcysteine (NAC) 600 mg, Curcumin (Turmeric) - HELICOBACTER PYLORI INFECTIONS
Phase 4CompletedUniversity of Thi-Qar1502026-01-202026-11-17
Saccharomyces Boulardii Combined With Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treatment
Bismuth, Esomeprazole, Tetracycline - Gastritis, Dyspepsia
Phase 4RecruitingYongquan Shi12482025-10-282025-12-02
Heartburn, Gastroesophageal Reflux Disease
Zastaprazan, Esomeprazole - GERD
Phase 4RecruitingIncheon St.Mary's Hospital1602025-07-072025-12-23
Vonoprazan Evaluation Compared to Standard Triple Therapy in Helicobacter Pylori eRadication
Vonoprazan 20mg, Esomeprazole 40 mg, Amoxicillin 1 g, Clarithromycin 500 mg - Helicobacter Pylori Infection
Phase 4RecruitingAsian Institute of Gastroenterology, India4842025-03-252025-06-11
Indonesian Study of Vonoprazan Vs Esomeprazole in Erosive Esophagitis
Vonoprazan 20 mg, Esomeprazole - Erosive Esophagitis
Phase 4Not yet recruitingUniversitas Indonesia2162024-12-092024-12-17
Efficacy and Safety of Vonorasan Versus Esomeprazole in the Treatment of Ulcers After Endoscopic Submucosal Dissection
Vonoprazan, Esomeprazole - Ulcers, Gastric
Phase 4RecruitingShicai Ye1962024-12-022026-11-02
Efficacy and Safety of Tegoprazan and Minocycline Dual Therapy for Helicobacter Pylori Initial Treatment
tegoprazan, Minocycline, bismuth potassium citrate - Helicobacter Pylori Infection Chronic Gastrit
Phase 4Active not recruitingXijing Hospital of Digestive Diseases2082024-11-112025-07-03
Study on The Efficacy and Safety of Vonoprazan-containing Berberine Triple Therapy in Helicobacter Pylori First-Line Eradication
Berberine, Vonoprazan, Amoxicillin - Helicobacter Pylori Infection, Chronic Gastritis
Phase 4CompletedXijing Hospital of Digestive Diseases5582024-09-202025-07-03
Optimal Duration of Bismuth Quadruple Therapy for Helicobacter Pylori Eradication in Females As Compared with Males
Drug: Bismuth Subcitrate 120 MG Oral Tablet, Esomeprazole 40mg, Metronidazole 250 MG - Helicobacter Pylori Infection, Sex
Phase 4Enrolling by invitationNational Cheng-Kung University Hospital6612024-07-092024-11-07
Efficacy and Safety of a Triple Eradication Scheme for Helicobacter Pylori Based on Tegoprazan vs Esomeprazole
Tegoprazan, Esomeprazole 40mg - Helicobacter Pylori Infection
Phase 4UnknownHospital General de México Dr. Eduardo Liceaga1602024-04-192024-03-19
The ESG Integrity Study: Effect of Proton Pump Inhibitors on the Structural Integrity of Endoscopic Sleeve Gastroplasty
Esomeprazole - Obesity
Phase 4UnknownFondazione Policlinico Universitario Agostino Gemelli IRCCS402024-02-012024-02-28
Levofloxacin Concomitant Versus Levofloxacin Sequential
sequential, Levofloxacin 500Mg Oral Tablet - Helicobacter Pylori Infection
Phase 4Not yet recruitingDamascus Hospital1502024-01-022023-10-03
Study on the Efficacy and Safety of Berberine, Minocycline, Esomeprazole, and Colloidal Bismuth Quadruple Therapy in the Initial Treatment of Helicobacter Pylori.
esomeprazole, Bismuth, Amoxicillin - Helicobacter Pylori Infection, Chronic Gastritis
Phase 4UnknownXijing Hospital of Digestive Diseases5482023-11-202024-09-19
Tegoprazan-Amoxicillin Dual Therapy vs. Bismuth Quadruple Therapy for H. Pylori Infection (TATH-1)
Tegoprazan 50 mg, tablets, orally, qd, Esomeprazole 20mg BID, Tegoprazan 50 mg, tablets, orally, bid - Helicobacter Pylori Infection
Phase 4CompletedZhang Xiaofeng,MD3702023-11-012026-01-16
Efficacy of Proton Pump Inhibitors in Cirrhotic Patients With Acute Variceal Bleeding
Proton Pump Inhibitors, No Proton Pump Inhibitors - Upper Gastrointestinal Hemorrhage
Phase 4Not yet recruitingWest China Hospital6722023-10-012023-09-28
Doxycycline for Helicobacter Pylori Rescue Treatment
Esomeprazole, Bismuth Potassium Citrate, Tetracycline - Helicobacter Pylori Infection
Phase 4RecruitingShanghai Jiao Tong University School of Medicine3682023-06-202024-12-30
Helicobacter Rescue Therapy With Vonorazon and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy
Vonoprazan, amoxicillin, Bismuth - Gastritis Dyspepsia Helicobacter Pylori Infection Gastric Cancer Peptic Ulcer
Phase 4CompletedYongquan Shi6882023-06-062025-07-03
PPI Infusion Versus Oral Acid Pump Inhibitors for Bleeding Peptic Ulcers
Vonoprazan, esomeprazole - Upper GI Bleeding, Proton Pump Inhibitors
Phase 4RecruitingChinese University of Hong Kong5942023-05-182026-03-18
A Study to Evaluate the Efficacy and Safety of Tegoprazan in GERD Patients With Nighttime Heartburn
Tegoprazan, Esomeprazole - Gastroesophageal Reflux Disease
Phase 4UnknownHK inno.N Corporation3382023-03-242023-08-03

Showing 20 of 152. Sign in to see all of them.

Conditions studied

Gastroesophageal Reflux (33)  ·  Heartburn (16)  ·  Dyspepsia (12)  ·  Gastritis (8)  ·  Peptic Ulcer (8)  ·  Stomach Neoplasms (5)  ·  Gastrointestinal Hemorrhage (4)  ·  Helicobacter Infections (4)  ·  Peptic Ulcer Hemorrhage (4)  ·  Stomach Ulcer (4)  ·  Barrett Esophagus (3)  ·  cyclopia sequence (3)  ·  Abdominal Pain (2)  ·  Acute Coronary Syndrome (2)  ·  Colorectal Neoplasms (2)

Sponsors

AstraZeneca (35)  ·  Shanghai Jiao Tong University School of Medicine (12)  ·  Xijing Hospital of Digestive Diseases (8)  ·  Damascus Hospital (5)  ·  Shandong University (5)  ·  National Taiwan University Hospital (4)  ·  Chinese University of Hong Kong (3)  ·  National Cheng-Kung University Hospital (3)  ·  Ruttonjee Hospital (3)  ·  Chang Gung Memorial Hospital (2)  ·  EMS (2)  ·  HK inno.N Corporation (2)  ·  Second Affiliated Hospital, Zhejiang University, School of Medicine (2)  ·  Seoul National University Bundang Hospital (2)  ·  Yongquan Shi (2)

Countries

China (43)  ·  United States (21)  ·  Taiwan (14)  ·  South Korea (6)  ·  Denmark (5)  ·  Syria (5)  ·  Germany (4)  ·  France (3)  ·  Greece (3)  ·  Netherlands (3)  ·  Sweden (3)  ·  Belgium (2)  ·  Brazil (2)  ·  Canada (2)  ·  Hong Kong (2)

Top investigators

Paula Fernstrom (11)  ·  Hong Lu, M.D. (3)  ·  Marouf M Alhalabi, MD (3)  ·  Yongquan Shi, Ph. D (3)  ·  Bor-Shyang Sheu, MD (2)  ·  Fook Hong Ng, MBBS (2)  ·  Hong Lu, M.D (2)  ·  Hong Lu, M.D.,Ph.D. (2)  ·  Jyh-Ming Liou, MD, PhD (2)  ·  Sang Kil Lee, Ph.D (2)  ·  Xiuli Zuo, MD,PhD (2)  ·  Andreas Franke, MD (1)  ·  Ansgar W Lohse, MD (1)

Results publications

PMID 32348007, PMID 15371921, PMID 15691312, PMID 25478944, PMID 25741163, PMID 27707777, PMID 28456631, PMID 29914954, PMID 34836916, PMID 12161727, PMID 12526935, PMID 16481828, PMID 16948806, PMID 17305763, PMID 18493207, PMID 19210493, PMID 19236727, PMID 19601705, PMID 20230209, PMID 20456300, PMID 20458079, PMID 20540767, PMID 20551454, PMID 20706150, PMID 21083590, PMID 21083673, PMID 21288053, PMID 21317257, PMID 21908799, PMID 22093203, PMID 22108447, PMID 22463723, PMID 22681960, PMID 22759841, PMID 22813439, PMID 23158886, PMID 23432146, PMID 24050512, PMID 24658598, PMID 24917966, PMID 25245625, PMID 25304129, PMID 25801708, PMID 26121347, PMID 26121348, PMID 26246908, PMID 26422095, PMID 26422096, PMID 27769562, PMID 28751088

NIH funding

2014 (1), 2019 (1), 2023 (1)